GlassScriptPhysician profile
Lukas James Williams
NPI 1265065619
$1,585.00
in general payments reported to CMS, 2019-2025
14 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.51 · 2022: $641 · 2023: $440 · 2024: $50.03 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $903.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $513.15 | 2022-2025 | |
| Genzyme Corporation | $229.27 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $201.70 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $183.97 | 2022-2023 | Nucala |
| Alk-Abello, INC | $157.47 | 2023-2025 | Neffy, Ragwitek, Grastek |
| Stryker Corporation | $66.30 | 2022 | |
| Smith+Nephew, INC. | $40.51 | 2021 | |
| Paratek Pharmaceuticals, INC. | $39.97 | 2025 | Nuzyra, Xhance |
| Phadia US INC. | $33.05 | 2022-2023 | Immunocap |
| Novartis Pharmaceuticals Corporation | $32.77 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $26.88 | 2025 | Tezspire |
| Merck Sharp & Dohme LLC | $23.36 | 2023 | |
| Watermark Medical, INC. | $20.43 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $16.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lukas Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.